EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | +62.5% | 26,782 | +459.9% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 4,783 | +168.4% | 0.00% | – |
| Q2 2022 | $55,000 | -24.7% | 1,782 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | +15.9% | 1,782 | +41.3% | 0.00% | – |
| Q3 2021 | $63,000 | -32.3% | 1,261 | -15.5% | 0.00% | – |
| Q2 2021 | $93,000 | -99.7% | 1,492 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $34,482,000 | +10.2% | 371,138 | +6.2% | 0.04% | +5.0% |
| Q4 2020 | $31,299,000 | -9.3% | 349,324 | +4.6% | 0.04% | -18.4% |
| Q3 2020 | $34,524,000 | +32.8% | 334,118 | +1.6% | 0.05% | +22.5% |
| Q2 2020 | $26,004,000 | +19.9% | 328,835 | -12.3% | 0.04% | 0.0% |
| Q1 2020 | $21,684,000 | -25.4% | 374,770 | -30.5% | 0.04% | -4.8% |
| Q4 2019 | $29,082,000 | -6.7% | 539,055 | -9.6% | 0.04% | -17.6% |
| Q3 2019 | $31,169,000 | -10.3% | 596,195 | -17.2% | 0.05% | -8.9% |
| Q2 2019 | $34,765,000 | – | 719,630 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |